| Product Code: ETC12568721 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
In 2024, Norway saw a steady increase in long-acting insulin imports, with the UK, Germany, USA, Denmark, and Metropolitan France emerging as the top exporting countries. Despite the growth, market concentration, as measured by the Herfindahl-Hirschman Index (HHI), remained low. The compound annual growth rate (CAGR) from 2020 to 2024 was a healthy 3.86%, indicating a consistent upward trend. Notably, the growth rate in 2024 spiked to 27.79%, showcasing a significant surge in demand for long-acting insulin in Norway.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Norway Long Acting Insulin Market Overview |
3.1 Norway Country Macro Economic Indicators |
3.2 Norway Long Acting Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Norway Long Acting Insulin Market - Industry Life Cycle |
3.4 Norway Long Acting Insulin Market - Porter's Five Forces |
3.5 Norway Long Acting Insulin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Norway Long Acting Insulin Market Revenues & Volume Share, By Delivery Method, 2021 & 2031F |
3.7 Norway Long Acting Insulin Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
3.8 Norway Long Acting Insulin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Norway Long Acting Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Norway |
4.2.2 Growing awareness about the benefits of long-acting insulin for diabetes management |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin products in Norway |
4.3.2 High cost associated with long-acting insulin treatment |
4.3.3 Limited access to healthcare services in certain regions of Norway |
5 Norway Long Acting Insulin Market Trends |
6 Norway Long Acting Insulin Market, By Types |
6.1 Norway Long Acting Insulin Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Norway Long Acting Insulin Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Norway Long Acting Insulin Market Revenues & Volume, By Lantus, 2021 - 2031F |
6.1.4 Norway Long Acting Insulin Market Revenues & Volume, By Levemir, 2021 - 2031F |
6.1.5 Norway Long Acting Insulin Market Revenues & Volume, By Tresiba, 2021 - 2031F |
6.1.6 Norway Long Acting Insulin Market Revenues & Volume, By Basaglar, 2021 - 2031F |
6.1.7 Norway Long Acting Insulin Market Revenues & Volume, By Toujeo, 2021 - 2031F |
6.2 Norway Long Acting Insulin Market, By Delivery Method |
6.2.1 Overview and Analysis |
6.2.2 Norway Long Acting Insulin Market Revenues & Volume, By Pen, 2021 - 2031F |
6.2.3 Norway Long Acting Insulin Market Revenues & Volume, By Syringe, 2021 - 2031F |
6.2.4 Norway Long Acting Insulin Market Revenues & Volume, By Pump, 2021 - 2031F |
6.2.5 Norway Long Acting Insulin Market Revenues & Volume, By Pre-filled Device, 2021 - 2031F |
6.3 Norway Long Acting Insulin Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 Norway Long Acting Insulin Market Revenues & Volume, By Type 1 Diabetes, 2021 - 2031F |
6.3.3 Norway Long Acting Insulin Market Revenues & Volume, By Type 2 Diabetes, 2021 - 2031F |
6.3.4 Norway Long Acting Insulin Market Revenues & Volume, By Gestational Diabetes, 2021 - 2031F |
6.4 Norway Long Acting Insulin Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 Norway Long Acting Insulin Market Revenues & Volume, By Solution, 2021 - 2031F |
6.4.3 Norway Long Acting Insulin Market Revenues & Volume, By Suspension, 2021 - 2031F |
7 Norway Long Acting Insulin Market Import-Export Trade Statistics |
7.1 Norway Long Acting Insulin Market Export to Major Countries |
7.2 Norway Long Acting Insulin Market Imports from Major Countries |
8 Norway Long Acting Insulin Market Key Performance Indicators |
8.1 Patient adherence rate to long-acting insulin therapy |
8.2 Rate of adoption of new insulin delivery technologies |
8.3 Number of healthcare facilities offering long-acting insulin treatments |
9 Norway Long Acting Insulin Market - Opportunity Assessment |
9.1 Norway Long Acting Insulin Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Norway Long Acting Insulin Market Opportunity Assessment, By Delivery Method, 2021 & 2031F |
9.3 Norway Long Acting Insulin Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
9.4 Norway Long Acting Insulin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
10 Norway Long Acting Insulin Market - Competitive Landscape |
10.1 Norway Long Acting Insulin Market Revenue Share, By Companies, 2024 |
10.2 Norway Long Acting Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here